Conference abstract · 2021
Research articlePublished 2015
Effect of Onabotulinum Toxin A on Substance P and Receptor Neurokinin 1 in the Rat Ventral Prostate
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: The objective of this work is to examine if sensory innervation impacts lower urinary tract symptoms (LUTS). Onabotulinum toxin A (BoNTA) has been used for the treatment of overactive and neurogenic bladder and as a treatment for LUTS secondary to benign prostatic hyperplasia (BPH). The mechanism of how BoNTA impacts LUTS/BPH is unclear. In rats, BoNTA injection causes prostate denervation, apoptosis and atrophy. In clinical trials reduced prostate size and LUTS are observed inconsistently, suggesting a neurologic component. We will examine if BoNTA treatment inhibits substance P production in sensory nerve fibers in the rat prostate. Methods: Twenty Sprague Dawley rats were divided into four groups including 1X PBS (control, n=6), 2.5 units Onabotulinum toxin A (BoNTA, n=6), 5 units BoNTA (n=6) injected into both lobes of the ventral prostate (VP) and sham surgery (n=2). Rats were Euthanized after one week. Substance P and its receptor neurokinin 1 localization and quantification were performed by counting the number of stained neurons and nerve bundles, by semiquantitative immunohistochemical analysis and by western analysis. Results: Substance P was localized in neuronal axons and bundles in the stroma of the VP but not in the epithelium. Receptor neurokinin 1 was identified in neuronal bundles of the stroma and in columnar epithelium of the VP ducts. Substance P decreased ~90% after BoNTA treatment (p=0.0001) while receptor neurokinin 1 did not change by IHC (p=0.213) or Western (p=0.3675). Conclusions: BoNTA treatment decreases substance P in the rat VP.
Keywords
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 20 Jul 2015
Minimally invasive therapy with intralesional onabotulinum toxin A in peyronie disease
Research article · 30 Aug 2021
Effect of a Benign Prostatic Hyperplasia (BPH) Xenobiotic - Croton Membranaceus M.Arg. Root Extract on CYP1A2, CYP3A4, CYP2D6, and GSTM1Drug Metabolizing Enzymes in Rat Model
Mini review · 22 Nov 2024
A Mini-Review of Holmium Laser Enucleation of the Prostate vs. Robot-Assisted Simple Prostatectomy for Managing LUTS Due to BPH
Research article · 14 Jun 2013
Effects of D-004, antioxidant and anti-inflammatory substances on testosterone-induced prostate hyperplasia in rats
More from this journal
The newest in Andrology-Open Access.
Commentary · 1 May 2026
Ultrasonic Treatment of Chicken Yolk: A Promising Strategy to Optimize Boar Semen Cryopreservation
Research article · 19 Feb 2026
Combining a Nitric Oxide Boosting Dietary Supplement with Sildenafil Improves Nighttime Erections more than Sildenafil alone
Mini review · 29 Dec 2025
Redefining Prostate Cancer Diagnosis: The Global Discourse on Single PSA Cut-Off Level in Diverse Populations
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAndrology-Open Access
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Omer Onur Cakir”
- BylineArticles whose byline prints “Carol A. Podlasek”
- BylineArticles whose byline prints “Douglas Wood”
- BylineArticles whose byline prints “Kevin E. McKenna”
- BylineArticles whose byline prints “Kevin T. McVary”

